Stock listing
gettex:83B 3SBio, Inc. Aktie
German listing (gettex) of 3SBio, Inc. · home listing HKEX:1530
Follow 3SBio, Inc. into a list and get an email when it puts out news.
Home listing price · HKEX:1530
$12.71 HKD -0.59 (-4.4%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:1530
- Day range
- $12.48 – $13.12 HKDNov 20, 2026
- Volume
- 15.78M sharesNov 20, 2026
- Market cap
- $31.47B HKDAt the close on Nov 20, 2026 · price × 2.48B shares outstanding
- 52-week range
- $12.48 – $32.80 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $316.1M HKDMedian day 17.69M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:1530 · Home | $12.71 HKD | -0.59 (-4.4%) | 15,783,742 | $13.12 | $13.12 | $12.48 | $13.30 | Close on Nov 20, 2026 |
| OTC:TRSBF | $1.82 USD | 0.00 (0.0%) | — | $1.82 | $1.82 | $1.82 | $1.82 | Close on Nov 17, 2026 |
| Frankfurt:83B | €1.445 EUR | -0.029 (-2.0%) | — | €1.439 | €1.445 | €1.439 | €1.474 | Close on Nov 20, 2026 |
| Munich:83B | €1.523 EUR | -0.056 (-3.5%) | — | €1.523 | €1.523 | €1.523 | €1.579 | Close on Nov 20, 2026 |
| Dusseldorf:83B | €1.457 EUR | -0.03 (-2.0%) | — | €1.438 | €1.457 | €1.438 | €1.487 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:1530 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $12.71 | -0.59 | -4.4% | $13.12 | $13.12 | $12.48 | 15,783,742 | |
| $13.30 | -0.56 | -4.0% | $13.80 | $13.81 | $13.11 | 14,574,708 | |
| $13.86 | -0.23 | -1.6% | $14.08 | $14.15 | $13.70 | 12,558,126 | |
| $14.09 | -0.35 | -2.4% | $13.70 | $14.44 | $13.52 | 19,294,500 | |
| $14.44 | -0.46 | -3.1% | $14.95 | $14.95 | $14.34 | 11,417,747 | |
| $14.90 | -0.07 | -0.5% | $14.68 | $15.08 | $14.60 | 10,771,166 | |
| $14.97 | -0.16 | -1.1% | $15.00 | $15.00 | $14.64 | 12,194,500 | |
| $15.13 | -0.03 | -0.2% | $15.23 | $15.49 | $14.97 | 11,353,000 | |
| $15.16 | -0.02 | -0.1% | $15.42 | $15.60 | $15.06 | 12,190,398 | |
| $15.18 | -0.16 | -1.0% | $14.80 | $15.64 | $14.80 | 15,087,074 | |
| $15.34 | +0.59 | +4.0% | $15.00 | $15.58 | $14.76 | 26,264,801 | |
| $14.75 | +0.82 | +5.9% | $13.93 | $14.78 | $13.85 | 26,882,686 | |
| $13.93 | +0.25 | +1.8% | $13.68 | $14.09 | $13.48 | 18,513,018 | |
| $13.68 | +0.14 | +1.0% | $13.58 | $13.93 | $13.40 | 12,889,291 | |
| $13.54 | -0.21 | -1.5% | $13.75 | $13.94 | $13.33 | 15,680,400 | |
| $13.75 | +0.06 | +0.4% | $13.80 | $14.20 | $13.66 | 18,094,702 | |
| $13.69 | +0.48 | +3.6% | $13.39 | $13.77 | $13.26 | 25,469,767 | |
| $13.21 | -0.70 | -5.0% | $13.91 | $13.96 | $13.05 | 26,658,860 | |
| $13.91 | -0.15 | -1.1% | $14.10 | $14.21 | $13.83 | 9,078,852 | |
| $14.06 | +0.43 | +3.2% | $13.63 | $14.19 | $13.32 | 23,949,180 | |
| $13.63 | -0.66 | -4.6% | $14.33 | $14.33 | $13.46 | 26,781,994 | |
| $14.29 | -0.41 | -2.8% | $14.96 | $15.00 | $14.16 | 14,695,454 | |
| $14.70 | +0.23 | +1.6% | $14.50 | $14.79 | $14.19 | 14,601,232 | |
| $14.47 | +0.11 | +0.8% | $14.68 | $14.91 | $14.30 | 17,751,596 | |
| $14.36 | -0.08 | -0.6% | $14.36 | $14.58 | $14.09 | 20,161,148 | |
| $14.44 | -0.32 | -2.2% | $14.76 | $14.76 | $14.34 | 23,201,336 | |
| $14.76 | +0.03 | +0.2% | $14.73 | $14.83 | $14.44 | 21,113,592 | |
| $14.73 | -0.34 | -2.3% | $15.20 | $15.23 | $14.67 | 23,107,223 | |
| $15.07 | +0.08 | +0.5% | $15.05 | $15.23 | $14.91 | 22,470,469 | |
| $14.99 | -0.71 | -4.5% | $15.90 | $16.26 | $14.93 | 34,507,723 | |
| $15.70 | -0.31 | -1.9% | $16.01 | $16.01 | $15.32 | 8,338,572 | |
| $16.01 | +0.47 | +3.0% | $15.60 | $16.14 | $15.50 | 6,492,848 | |
| $15.54 | -0.31 | -2.0% | $15.85 | $15.85 | $15.39 | 7,683,852 | |
| $15.85 | -0.72 | -4.3% | $16.20 | $16.20 | $15.50 | 10,727,463 | |
| $16.57 | +0.65 | +4.1% | $15.87 | $16.61 | $15.70 | 31,189,266 | |
| $15.92 | +0.30 | +1.9% | $15.90 | $16.35 | $15.61 | 40,551,551 | |
| $15.62 | -0.36 | -2.3% | $15.97 | $16.24 | $15.52 | 14,863,012 | |
| $15.98 | -0.24 | -1.5% | $16.32 | $16.32 | $15.71 | 4,157,500 | |
| $16.22 | -0.79 | -4.6% | $17.00 | $17.00 | $16.11 | 13,262,810 | |
| $17.01 | +0.24 | +1.4% | $16.87 | $17.35 | $16.75 | 17,194,607 | |
| $16.77 | -0.45 | -2.6% | $17.12 | $17.19 | $16.53 | 25,720,885 | |
| $17.22 | +1.47 | +9.3% | $16.00 | $17.24 | $15.94 | 33,844,309 | |
| $15.75 | -0.23 | -1.4% | $16.06 | $16.20 | $15.75 | 15,920,414 | |
| $15.98 | +0.30 | +1.9% | $15.78 | $16.10 | $15.60 | 9,587,336 | |
| $15.68 | -0.35 | -2.2% | $15.95 | $16.10 | $15.60 | 13,912,889 | |
| $16.03 | -0.19 | -1.2% | $16.21 | $16.29 | $15.95 | 10,229,944 | |
| $16.22 | +0.78 | +5.1% | $15.41 | $16.34 | $15.20 | 19,604,615 | |
| $15.44 | -0.10 | -0.6% | $15.55 | $15.67 | $15.10 | 19,171,713 | |
| $15.54 | -0.61 | -3.8% | $16.12 | $16.12 | $15.48 | 35,811,207 | |
| $16.15 | -0.28 | -1.7% | $16.34 | $16.34 | $15.93 | 16,834,176 | |
| $16.43 | +0.39 | +2.4% | $16.20 | $16.63 | $15.87 | 15,426,469 | |
| $16.04 | -0.20 | -1.2% | $16.17 | $16.22 | $15.81 | 9,889,784 | |
| $16.24 | -0.05 | -0.3% | $16.48 | $16.88 | $16.17 | 17,618,746 | |
| $16.29 | +0.44 | +2.8% | $15.99 | $16.37 | $15.95 | 14,381,182 | |
| $15.85 | -0.21 | -1.3% | $15.91 | $15.95 | $15.58 | 23,056,695 | |
| $16.06 | -0.06 | -0.4% | $16.20 | $16.30 | $15.80 | 16,823,867 | |
| $16.12 | -0.84 | -5.0% | $16.84 | $16.84 | $15.94 | 34,870,953 | |
| $16.96 | -0.19 | -1.1% | $17.26 | $17.40 | $16.84 | 18,779,072 | |
| $17.15 | -0.38 | -2.2% | $17.80 | $17.88 | $17.10 | 27,655,805 | |
| $17.53 | -0.13 | -0.7% | $17.66 | $18.10 | $17.44 | 25,257,199 | |
| $17.66 | -0.24 | -1.3% | $17.90 | $18.01 | $17.31 | 21,974,580 | |
| $17.90 | +0.07 | +0.4% | $17.83 | $18.25 | $17.61 | 29,610,102 | |
| $17.83 | +1.33 | +8.1% | $16.42 | $18.65 | $16.20 | 71,334,195 | |
| $16.50 | -0.19 | -1.1% | $17.29 | $17.85 | $16.34 | 58,539,477 |
- Ticker
- gettex:83B
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Latest deck · Aug 21, 2026
H1 2026 Earnings Presentation
Earnings · 31 slides
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 2, 2026
Closed $13.93 (+1.8%) on Nov 3, 2026
Next Day Disclosure Return
Oct 14, 2026
Closed $14.36 (-0.6%) on Oct 15, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 2, 2026
Closed $15.54 (-2.0%) on Oct 5, 2026
2026 Interim Report
Sep 30, 2026
Closed $15.85 (-4.3%) on Oct 2, 2026
3SBio, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 11 in the last 12 months · 32 in all · newest Nov 2, 2026 · oldest 2020
- Decks
- 27 decks · latest Aug 21, 2026
Where 3SBio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:1530 三生製藥 · Home listing | HKEX | Hong Kong | HKD |
| OTC:TRSBF | OTC | United States | USD |
| gettex:83B · This page | gettex | Germany | EUR |
| LS Exchange:A14T7Q | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14T7Q | Lang & Schwarz | Germany | EUR |
| Frankfurt:83B | Frankfurt | Germany | EUR |
| Munich:83B | Munich | Germany | EUR |
| Dusseldorf:83B | Dusseldorf | Germany | EUR |
| Stuttgart:83B | Stuttgart | Germany | EUR |
| Tradegate:83B | Tradegate | Germany | EUR |
Valuation
P/E 3.2× against a median of 23.6×: the lowest of 9 Pharmaceuticals companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $12.45B HKD
- P/E
- 3.2×
- EV/sales
- 0.6×
- EV/EBITDA
- 1.0×
- Price/book
- 1.0×
- Gross margin
- 92.4%
- Operating margin
- 59.6%
- Net margin
- 47.9%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| 3SBio, Inc. · HKEX:1530 | US$4.02B | US$1.59B | 3.2× | 0.6× | 1.0× | 1.0× | 47.9% | 0.1× | n/a |
| Ajanta Pharma Limited · NSE:AJANTPHARM | US$4.47B | US$4.42B | 32.8× | 6.6× | 16.1× | 8.5× | 20.3% | 0.0× | n/a |
| Aspen Pharmacare Holdings Limited · JSE:APN | US$4.39B | US$4.36B | 29.1× | 2.2× | 10.5× | 1.0× | 7.6% | 0.2× | n/a |
| Camurus AB · OMXSTO:CAMX | US$4.30B | US$3.88B | 58.3× | 16.4× | 42.4× | 8.8× | 31.2% | 0.0× | n/a |
| Hubei Jumpcan Pharmaceutical Co., Ltd Class A · SSE:600566 | US$4.30B | US$2.54B | 15.8× | 2.9× | n/a | 2.0× | 30.7% | 0.0× | n/a |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A · SZSE:002294 | US$4.30B | US$4.15B | n/a | n/a | n/a | 3.3× | n/a | 0.1× | n/a |
| Wockhardt Limited · NSE:WOCKPHARMA | US$3.83B | US$4.00B | 86.6× | 9.9× | 51.4× | 6.9× | 10.9% | 0.4× | n/a |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A · SZSE:002603 | US$3.72B | US$3.34B | 18.0× | 2.8× | n/a | 2.2× | 17.4% | 0.0× | n/a |
| Organon & Co. · NYSE:OGN | US$3.65B | US$10.75B | 17.1× | 1.8× | n/a | 3.1× | 3.5% | 7.2× | 0.52 |
| Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS | US$3.60B | US$3.36B | n/a | 4.9× | n/a | 34.6× | −102.9% | 0.7× | 0.62 |
| Laboratorios Farmaceuticos Rovi, S.A. · BME:ROVI | US$3.54B | US$3.52B | 17.4× | 4.2× | 15.8× | 4.6× | 23.9% | 0.1× | n/a |
| Median of the others | US$4.06B | US$3.94B | 23.6× | 4.2× | 16.1× | 4.0× | 17.4% | 0.1× | 0.57 |
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 29.30 HKD · Analysts' mean
- EPS, year to Dec 2026
- 1.02 · 3 analysts
- Revenue, year to Dec 2026
- 9.45B · 14 analysts
Team and board
| Officer | Role |
|---|---|
| Tony He | Chief Financial Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Aug 20, 2025 · Before open | −3.4% |
| Quarter to Mar 31, 2025 | Apr 30, 2025 | +9.5% |
| Q4 2024 | Mar 25, 2025 | +1.7% |
| Quarter to Sep 30, 2024 | Nov 18, 2024 | −0.5% |
| Q2 2024 | Aug 22, 2024 | −11.0% |
| Quarter to Mar 31, 2024 | May 22, 2024 | −1.7% |
| Q4 2023 | Mar 20, 2024 | +1.3% |
| Quarter to Sep 30, 2023 | Nov 15, 2023 | +3.1% |
| Q2 2023 | Aug 24, 2023 · Before open | +2.7% |
| Q1 2023 | May 17, 2023 | −3.7% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Mar 21, 2023 · Before open | +0.9% |
| Q3 2022 | Nov 16, 2022 | +0.1% |
| Q2 2022 | Aug 24, 2022 · Before open | +0.2% |
| Q1 2022 | May 18, 2022 | +1.4% |
| Q4 2021 | Mar 28, 2022 · After close | +4.3% |
| Q3 2021 | Nov 17, 2021 | −2.5% |
| Q2 2021 | Aug 25, 2021 · Before open | +0.1% |
| Q1 2021 | May 19, 2021 | +1.7% |
| Q4 2020 | Feb 26, 2021 · Before open | −6.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 31 slides | Aug 21, 2026 |
| FY2025 Earnings Presentation | Earnings | 31 slides | Mar 31, 2026 |
| J.P. Morgan 2026 Healthcare Conference | Conference | 30 slides | Jan 15, 2026 |
| H1 2025 Earnings Presentation | Earnings | 44 slides | Sep 1, 2025 |
| FY2024 Earnings Presentation | Earnings | 48 slides | Mar 26, 2025 |
| 43rd Annual J.P. Morgan Healthcare Conference (January 2025) | Conference | 43 slides | Jan 16, 2025 |
| H1 2024 Earnings Presentation | Earnings | 40 slides | Aug 23, 2024 |
| FY2023 Earnings Presentation | Earnings | 46 slides | Mar 21, 2024 |
| H1 2023 Earnings Presentation | Earnings | 43 slides | Aug 24, 2023 |
| FY2022 Earnings Presentation | Earnings | 46 slides | Mar 21, 2023 |
All 27 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2022 Earnings Presentation | Earnings | 43 slides | Aug 25, 2022 |
| FY2021 Earnings Presentation | Earnings | 45 slides | Mar 28, 2022 |
| H1 2021 Earnings Presentation | Earnings | 48 slides | Aug 25, 2021 |
| FY2020 Earnings Presentation | Earnings | 30 slides | Mar 31, 2021 |
| H1 2020 Earnings Presentation | Earnings | 30 slides | Jul 18, 2020 |
| FY2019 Earnings Presentation | Earnings | 30 slides | Mar 31, 2020 |
| H1 2019 Earnings Presentation | Earnings | 36 slides | Aug 22, 2019 |
| FY2018 Earnings Presentation | Earnings | 36 slides | Mar 21, 2019 |
| H1 2018 Earnings Presentation | Earnings | 35 slides | August 2018 |
| FY2017 Earnings Presentation | Earnings | 36 slides | March 2018 |
| FY2016 Earnings Presentation | Earnings | 36 slides | Jun 14, 2017 |
| FY2016 Earnings Presentation | Earnings | 36 slides | Jun 13, 2017 |
| H1 2016 Earnings Presentation | Earnings | 33 slides | August 2016 |
| H1 2016 Earnings Presentation | Earnings | 33 slides | 2016 |
| H1 2015 Earnings Presentation | Earnings | 29 slides | August 2015 |
| H1 2015 Earnings Presentation | Earnings | 29 slides | 2015 |
| FY2012 Earnings Presentation | Earnings | 31 slides | Mar 18, 2013 |
Financials
Annual, in CNY
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.7B | 9.11B | 7.82B | 6.86B | 6.38B | 5.59B | 5.32B | 4.58B | 3.73B | 2.80B |
| Cost of revenue | 1.35B | 1.28B | 1.17B | 1.19B | 1.11B | 1.06B | 925.3M | 877.3M | 676.2M | 402.3M |
| Gross profit | 16.3B | 7.83B | 6.64B | 5.67B | 5.28B | 4.52B | 4.39B | 3.71B | 3.06B | 2.40B |
| Research and development | 1.52B | 1.33B | 794.8M | 693.2M | 753.9M | 590.3M | 526.6M | 362.7M | 257.3M | 243.0M |
| Selling, general and administrative | 641.9M | 501.9M | 480.8M | 384.7M | 371.5M | 452.8M | 676.0M | 316.8M | 315.1M | 301.2M |
| Operating income | 10.5B | 2.65B | 2.46B | 2.07B | 1.83B | 1.46B | 1.34B | 1.44B | 1.16B | 908.8M |
| Depreciation and amortization | 530.4M | 394.9M | 334.8M | 368.0M | 329.0M | 360.9M | 334.0M | 313.3M | 243.7M | 161.0M |
| EBITDA | 11.1B | 3.04B | 2.79B | 2.44B | 2.16B | 1.82B | 1.67B | 1.76B | 1.40B | 1.07B |
| Interest expense | 74.4M | 190.8M | 212.3M | 102.7M | 66.5M | 81.1M | 109.5M | 138.4M | 141.3M | 147.7M |
| Income before tax | 10.7B | 2.72B | 1.98B | 2.27B | 1.87B | 979.1M | 1.22B | 1.50B | 1.10B | 850.1M |
| Income tax | 1.65B | 500.5M | 392.2M | 370.7M | 241.2M | 208.0M | 242.8M | 218.3M | 177.6M | 135.8M |
| Net income | 8.48B | 2.09B | 1.55B | 1.92B | 1.65B | 835.8M | 973.7M | 1.28B | 935.4M | 712.6M |
| Earnings per share, basic | 3.44 | 0.85 | 0.63 | 0.72 | 0.60 | 0.33 | 0.38 | 0.46 | 0.35 | 0.28 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12.3B | 2.02B | 2.69B | 2.15B | 2.80B | 3.09B | 2.08B | 1.79B | 2.40B | 674.4M |
| Short-term investments | 7.41B | 3.77B | 3.30B | 4.86B | 1.90B | 1.27B | 472.2M | 68.1M | 704.6M | 362.2M |
| Receivables | 1.08B | 1.71B | 85.4M | 1.31B | 1.38B | 983.0M | 1.30B | 1.48B | 1.32B | 785.5M |
| Inventory | 1.05B | 795.2M | 777.5M | 712.2M | 690.5M | 619.5M | 528.5M | 384.6M | 376.5M | 262.4M |
| Current assets | 22.7B | 9.35B | 9.19B | 9.76B | 7.79B | 6.68B | 4.60B | 4.44B | 5.28B | 2.24B |
| Property, plant and equipment | 5.59B | 5.15B | 4.47B | 3.83B | 2.98B | 2.32B | 1.79B | 1.76B | 1.76B | |
| Goodwill | 4.17B | 4.25B | 4.20B | 4.14B | 3.84B | 3.92B | 4.15B | 4.09B | 3.92B | 4.13B |
| Total assets | 36.3B | 24.2B | 23.6B | 22.0B | 19.2B | 17.7B | 14.8B | 13.8B | 13.8B | 11.0B |
| Accounts payable | 244.8M | 179.6M | 212.1M | 249.5M | 230.4M | 203.3M | 149.8M | 112.9M | 274.6M | 58.8M |
| Current liabilities | 4.42B | 5.46B | 3.73B | 1.79B | 1.42B | 1.45B | 1.61B | 1.66B | 2.20B | 1.14B |
| Long-term debt | 723.3M | 37.6M | 2.69B | 4.07B | 2.44B | 2.51B | 2.32B | 2.72B | 3.32B | 2.54B |
| Total debt | 2.62B | 3.55B | 4.84B | 4.52B | 2.63B | 2.91B | 2.81B | 3.29B | 4.41B | 3.06B |
| Total liabilities | 5.82B | 6.18B | 7.11B | 6.59B | 4.55B | 4.58B | 4.45B | 4.93B | 6.12B | 4.27B |
| Shareholders' equity | 27.2B | 15.4B | 14.0B | 13.0B | 12.2B | 10.7B | 9.63B | 8.61B | 7.40B | 6.52B |
| Shares outstanding | 2.47B | 2.47B | 2.44B | 2.65B | 2.77B | 2.54B | 2.54B | 2.75B | 2.65B | 2.56B |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 9.67B | 3.20B | 2.08B | 2.18B | 1.58B | 1.34B | 1.89B | 1.15B | 1.07B | 1.00B |
| Capital spending | -541.4M | -963.2M | -704.3M | -973.7M | -1.15B | -981.5M | -486.3M | -433.4M | -243.1M | -466.0M |
| Free cash flow | 9.13B | 2.24B | 1.38B | 1.21B | 432.6M | 363.1M | 1.40B | 716.8M | 831.0M | 538.3M |
| Cash from investing | -1.83B | -1.36B | -1.35B | -3.72B | -1.29B | -1.87B | -1.13B | -405.9M | -643.2M | -4.38B |
| Cash from financing | 2.35B | -2.25B | -353.0M | 763.2M | -481.1M | 1.55B | -454.4M | -1.39B | 1.32B | 2.71B |
| Dividends paid | -559.8M | -555.1M | -224.9M | -417.1M | 0 | -16.3M | -150.8M | -150.8M | -150.8M | |
| Share buybacks | 0 | -242.4M | 337.0K | -475.7M | -412.9M | -11.2M | -38.2M | -40.6M | 0 | |
| Change in cash | 10.0B | -468.5M | 459.4M | -717.8M | -222.8M | 1.01B | 290.2M | -606.0M | 1.72B | -621.8M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026 | Nov 2, 2026 | Monthly return | HKEX |
| Next Day Disclosure Return | Oct 14, 2026 | Next day disclosure return | HKEX |
| Next Day Disclosure Return | Oct 13, 2026 | Next day disclosure return | HKEX |
| Next Day Disclosure Return | Oct 12, 2026 | Next day disclosure return | HKEX |
| Next Day Disclosure Return | Oct 9, 2026 | Next day disclosure return | HKEX |
| Next Day Disclosure Return | Oct 8, 2026 | Next day disclosure return | HKEX |
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 | Oct 2, 2026 | Monthly return | HKEX |
| 2026 Interim Report | Sep 30, 2026 | Interim report | HKEX |
| Next Day Disclosure Return | Sep 29, 2026 | Next day disclosure return | HKEX |
| Next Day Disclosure Return | Sep 28, 2026 | Next day disclosure return | HKEX |
Cap table
Built by 6ix from 3SBio, Inc.’s releases
- Common shares
- 2,476,392,002
- Fully diluted
- 2,476,392,002
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 2,476,392,002 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 2,476,392,002 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Tony He | Chief Financial Officer · Since at least Jan 21, 2025 |
Log in to ask 6ix AI your own questions about 3SBio, Inc.